Publication Name	World Journal of Clinical Cases
Manuscript ID	53310
Country	China

Received	2019-12-15 06:19
Peer-Review Started	2019-12-15 06:22
To Make the First Decision
Return for Revision	2019-12-30 09:34
Revised	2020-01-06 06:11
Second Decision	2020-01-09 10:01
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2020-01-11 13:57
Articles in Press	2020-01-11 13:57
Publication Fee Transferred
Edit the Manuscript by Language Editor	2020-01-13 13:25
Typeset the Manuscript	2020-01-19 02:14
Publish the Manuscript Online	2020-02-06 02:37

ISSN	2307-8960 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Case Report
Article Title	Camrelizumab (SHR-1210) leading to reactive capillary hemangioma in gingiva: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Qing Yu and Wen-Xia Wang
ORCID	Author(s) ORCID Number Qing Yu http://orcid.org/0000-0003-3686-6490 Wen-Xia Wang http://orcid.org/0000-0003-4893-7604
Funding Agency and Grant Number
Corresponding Author	Wen-Xia Wang, PhD, Doctor, Department of Periodontology, School and Hospital of Stomatology, Shandong University, Shandong Key Laboratory of Oral Tissue Regeneration and Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, No. 44-1 Wenhua Road West, Jinan 250012, Shandong Province, China. wangwx@sdu.edu.cn
Key Words	Camrelizumab; Adverse effects; Reactive capillary hemangioma; Gingiva; Case report;
Core Tip	Camrelizumab (SHR-1210) is a kind of anti-PD-1 antibody. It was reported that a unique treatment-related adverse event was reactive capillary hemangioma. Notably, most reactive capillary hemangiomas occur on the skin, and this side effect is rarely seen in oral tissues. In this report, we describe a case of a patient who experienced gingival reactive capillary hemangioma during SHR-1210 treatment for lung cancer.
Publish Date	2020-02-06 02:37
Citation	Yu Q, Wang WX. Camrelizumab (SHR-1210) leading to reactive capillary hemangioma in gingiva: A case report. World J Clin Cases 2020; 8(3): 624-629
URL	https://www.wjgnet.com/2307-8960/full/v8/i3/624.htm
DOI	https://dx.doi.org/10.12998/wjcc.v8.i3.624

Full Article (PDF)	WJCC-8-624.pdf
Full Article (Word)	WJCC-8-624.docx
CARE Checklist–2016	53310-CARE-Checklist–2016-revision.pdf
Manuscript File	53310-Review_WangTQ.docx
Answering Reviewers	53310-Answering reviewers.pdf
Audio Core Tip	53310-Audio core tip.wav
Conflict-of-Interest Disclosure Form	53310-Conflict-of-interest statement.pdf
Copyright License Agreement	53310-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	53310-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	53310-Language certificate.pdf
Peer-review Report	53310-Peer-review(s).pdf
Scientific Misconduct Check	53310-Scientific misconduct check.pdf
Scientific Editor Work List	53310-Scientific editor work list.pdf